Mankind Cefastar CV 100 mg Tablet (Cefpodoxime & Clavulanic Acid) for Dogs and Cats

Product Type: Veterinary antibiotic tablet
Active Ingredients:

• Cefpodoxime Proxetil – 100 mg

• Clavulanic Acid – 62.5 mg

Suitable For: Dogs and cats

Indications / Uses

Mankind Cefastar CV may be used under veterinary supervision for the treatment of susceptible bacterial infections, including:

• Respiratory tract infections

• Skin and soft tissue infections

• Urinary tract infections

• Other bacterial infections that are susceptible to the cefpodoxime and clavulanic acid combination

How It Works

Cefpodoxime is a cephalosporin-class antibacterial agent that acts by interfering with bacterial cell-wall synthesis. Clavulanic acid is included to help inhibit certain bacterial resistance mechanisms that can reduce the effectiveness of some beta-lactam antibiotics. Together, the combination is intended to provide antibacterial activity against susceptible organisms.

Directions for Use

Administer the tablet orally according to the veterinarian's prescribed dosage and treatment schedule. The supplied information states that it may be given with or without food. Giving the medicine at approximately the same time each day can help maintain a consistent treatment routine.

The appropriate dose and duration depend on factors such as the animal's body weight, infection, clinical condition, and veterinary assessment. Do not determine the treatment dose solely from the product strength.

Antibiotic treatment should be continued for the complete duration prescribed by the veterinarian, even if the animal appears to improve earlier. Stopping treatment prematurely or using antibiotics without appropriate veterinary guidance can contribute to inadequate treatment and antimicrobial resistance.

Important Veterinary Considerations

This product is an antibiotic intended for veterinary use in dogs and cats. It should be used only when considered appropriate for the animal's suspected or confirmed bacterial infection. The supplied information does not provide a specific weight-based dosage chart, treatment duration, contraindications, adverse-effect profile, or drug-interaction list; these details should therefore be confirmed from the current product packaging and veterinary prescription rather than assumed.